Anti‑hyperlipidaemic activity of fresh and old Guggulu (Commiphora wightii (Arn.) Bhandari) in experimental animals

Kruti Yagneshkumar Vyas, Mukeshkumar Nariya, R Galib, Pradeep Kumar Prajapati


Objective: Guggulu (Commiphora wightii (Arn.) Bhandari) belong to family Burseraceae is a well‑known anti‑hyperlipidaemic drug. An Ayurvedic classic attributes brihmana (weight increasing) effect to fresh Guggulu, while lekhana (weight reducing) effect to the old one. Though anti‑hyperlipidaemic activity of Guggulu has been studied, the actual differentiation in efficacy of Guggulu samples during storage period has not yet attempted in experimental animals. This prompted us to initiate a comparative anti‑hyperlipidaemic activity of fresh Guggulu
and one‑year old Guggulu samples against cholesterol diet induced hyperlipidaemia in rats. Materials and Methods: Hyperlipidaemia was induced by cholesterol (0.5 ml/kg, 20% suspension in coconut oil) and hydrogenated vegetable oil (5 ml/kg). The effects of drugs were assessed on body weight, serum biochemical parameters and histological parameters. Results: Both drugs produced significant attenuation
of relative weight of liver in cholesterol‑fed animals. Fresh sample of Guggulu provided better effect in lowering serum cholesterol (15.34%), triglyceride (34.72%), very low density lipoprotein (34.7%) and low density lipoprotein (18.66%) and non‑significant increase in serum HDL‑cholesterol while old sample of Guggulu provided mild effect in lowering serum triglyceride (6.47%), VLDL (6.49%) and LDL (29.50%) and non‑significant increase in serum HDL‑cholesterol in comparison with control group. Conclusion: From the present study, it is concluded that fresh Guggulu produced pronounced hyperlipidaemic effect than the old one in experimental animals, which may be due the presence of higher concentration of Z‑guggulsterone and E‑guggulsterone.
Key words: Anti‑hyperlipidaemia, Commiphora wightii, Guggulsterone, Guggulu

Full Text:



In: Sainani GS, editor. API Textbook of Medicine. 6th ed. Mumbai:

Association of Physicians of India; 1999. p. 191.

In: Alwan A, editor. Global Status Report on Non‑Communicable

Diseases 2010. Genewa: World Health Organization; reprinted:2011.

Rout OP, Acharya R, Mishra SK. Oleogum resin Guggulu: A review

of the medicinal evidence for its therapeutic properties. Int J Res

Ayurveda Pharm 2012;3:15‑21.

In: Acharya YT editor. Sushruta Samhita of Sushruta, Sutra sthana

/32. Nibandha smgraha Commentary by Dalhanacharya.

Varanasi: Chaukhambha Surbharti Prakashan; reprint 2003. p. 73.

Satyavati GV. Effect of an indigenous drug on disorders of

lipid metabolism with special reference to atherosclerosis and

obesity (Medoroga). M.D. Ayu Thesis (Doctarate of Ayurvedic

Medicine). Varanasi: Banaras Hindu University; 1966.

Agarwal RC, Singh SP, Saran PK. Clinical trial of guggulipid‑A new

hypolipedemic agent of plant origin in primary Hyperlipidaemia.

Indian J Med Res 1986;84:626.

Nityanand S, Shrivastav JS, Asthana OP. Clinical trials with

gugulipid‑ A new hyperlipidaemic agent. J Assoc Phys India


In: Mishra B, Vaisya R, editors. Bhavaprakasha of Shri

Bhavamishra, Purva khanda, Karpuradi Varga/42. Vidhyodini

Hindi Commentary, Vol. 1. 9th ed. Varanasi: Chaukhambha Sanskita

Bhavana; 2002. p. 205.

In: Shastri R, editor. Bhaishajya Ratnavali of Shri Govinda Das.

Paribhasha Prakarana, 4/14. Vidhyodini hindi Commentary.

th ed. Varanasi: Chaukhambha Prakashana; 2010. p. 49.

In: Mishra B, editor. Bhavaprakasha of Shri Bhavamishra, Uttara

khanda, Vatarakta Chikitsa/187, Vidhyodini hindi Commentary,

Vol. 2. 7th ed. Varanasi: Chokhambha Sanskita Bhavana; 2010. p. 316.

In: Vidhyasagar P, editor. Sarngadhara Samhita of

Sarngadharacarya, Prathama Khanda, 1/44. 6th ed. Varanasi:

Chaukhamba Surbharati Prakashana; 2005. p. 11.

Ayurvedic Formulary of India, part‑1, volume II. 2nd ed. Guggulu.

New Delhi: Dept. of ISM and H, Ministry of Health and Family

Welfare, Govt. of India; 2003. p. 58.

The Ayurvedic Pharmacopoeia of India, part‑1, volume I. 1st ed.

New Delhi: Dept. of ISM and H, Ministry of Health and Family

Welfare, Govt. of India; 1999. p. 56‑57.

Paget GE, Barnes JM. Evaluation of drug activities. In: Laurence DR,

Bacharach AL, editors. Pharmacometrics, vol. 1. 1st ed. London:

Academic Press; 1964. p. 50.

Nadkarni M. Clinico experimental study of hyperlipidaemia

and its management by mustadighanavati. MDAyu dissertation.

Jamnagar: Institute of Post Graduate Teaching and Research in

Ayurveda, Gujarat Ayurved University; 2009.

Roeschlau P, Bernt E, Gruber WA. Enzymatic determination of

total cholesterol in serum. Clin Biochem 1974;12:226‑8.

N a u k M , Wi e b e D , Wa r n i c k G . M e a s u r e m e n t o f

high‑density‑lipoprotein cholesterol. In: Rifai N, Warnick GR,

Dominiczak M, editors. Handbook of Lipoprotein Testing. 2nd ed.

Washington DC: AACC Press; 2000. p. 221‑44.

Fossati P, Prencipe L. Serum triglycerides determined

colorimetrically with an enzyme that produces hydrogen peroxide.

Clin Chem 1982;28:2077‑80.

In: Tietz NW, editor. Clinical Guide to Laboratory Tests. 3rd ed.

Philadelphia: WB Saunders; 1995. p. 76.

In: Burtis CA, Ashwood ER, Burns DE, editors. Tietz Textbook of

Clinical Chemisry. 3rd ed. Philadelphia: WB Saunders; 1999. p. 652.

Wilkinson JH, Boutwell JH, Winsten S. Evaluation of a new system

for kinetic measurement of serum alkaline phosphatase. Clin Chem


Raghramulu N, Nair MK, Kalyansundaram S. A Manual of

Laboratory technique. Hydrabad: National Institute of Nutrition,

Jamai Osmania; 1983. p. 92.

Roberts WC. Preventing and arresting coronary atherosclerosis.

Am Heart J 1995;130:580‑600.

Scandinavian simvastatin survival study group. Randomised

trial of cholesterol lowering in 4444 patients with coronary heart

disease: The Scandinavian simvastatin survival study (4S). Lancet


Jasuja ND, Choudhary M, Sharama P, Sharma N, Joshi SC.

A review on bioactive compounds and medicinal uses of

Commiphora mukul. J Plant Sci 2012;7:113‑37.

Vyas KY. Evaluation of fresh (naveena) and old (purana) Guggulu

w.s.r. to their anti hyperlipidaemic (medohara) effect. MD Ayu

dissertation. Jamnagar: Institute of Post Graduate Teaching and

Research in Ayurveda, Gujarat Ayurved University; 2013.

Wang Y, Zhang B, Xue Y, Li Z, Wang J, Xue C, et al. The mechanism

of dietary cholesterol effects on lipids metabolism in rats. Lipids

Health Dis 2010;9:4.

Talwar GP. Textbook of Biochemistry and Human Biology. 1st ed.

New Delhi: Prentice Hall of India Pvt Ltd; 1980. p. 349‑53.

Barter P. The role of HDL‑cholesterol in preventing atherosclerotic

disease. Eur Heart J Suppl 2005;7(Suppl F):F4‑8.

Satyanarayan U. Essential of Biochemistry. 2nd revised ed. Kolkata:

Books and Allied Ltd; 2002.

Gupta A, Kapoor NK, Nityanand S. Mechanism of hypolipidemic

action of standardized extract. Indian J Pharmacol 1982;14.

Singh V, Kaul S, Chander R, Kapoor NK. Simultaneous low density

lipoprotein receptor activity in liver membrane of guggulsterone

treated rats. Pharmacol Res 1990;22:37‑44.

Tripathi YB, Malhotra OP, Tripathi SN. Thyroid‑stimulating action

of Z‑guggulsterone obtained from Commiphora mukul. Planta Med




  • There are currently no refbacks.